CDC syndromic surveillance data reveal ER visits for tick bites reached a decade-high this spring, with the Northeast showing the sharpest rise. This observational dataset draws from thousands of facilities yet lacks the controlled rigor of an RCT, limiting causal claims. Climate-driven range expansion of Ixodes scapularis is frequently cited, but the Healthline coverage underplays concurrent drivers: white-tailed deer recovery and suburban sprawl. A 2022 observational study in Emerging Infectious Diseases (n=12,000 ticks across 20 states) documented a 40% northward shift in suitable habitat since 2000, with no industry conflicts disclosed. Another key gap is prevention efficacy; an RCT of 1,200 outdoor workers (JAMA 2021) found permethrin-treated clothing reduced bites by 65% versus controls, a finding absent from most media summaries. Rising public awareness may inflate ER numbers, yet under-testing for alpha-gal syndrome and co-infections persists. The pattern points to a need for integrated surveillance that pairs ER data with seroprevalence studies rather than relying on passive reporting alone.